The University of Western Australia Unveils MBA (Global) Online Program to Empower Leaders with Advanced Business Skills
Reading Time: 3 minutes Mumbai, Maharashtra, India: The University of Western Australia (UWA) is excited to announce its Batch 8, a highly anticipated Master of Business Administration (MBA) (Global) program. This innovative program offers professionals the opportunity to pursue an online MBA without taking a break
Belgian Meat Office Continues the Journey of Showcasing ‘The Art of European Pork’ in India Through the Exclusive Chef Workshop Series in Delhi, Mumbai and Bangalore
Reading Time: 3 minutes As part of the “The Art of European Pork” campaign, Belgian Meat Office recently organized an exclusive series of chef demonstrations across India, with events held in New Delhi, Mumbai, and Bengaluru. These demonstrations celebrated the excellence of Belgian pork and provided Indian professional chefs
EQL Pharma AB (publ) signs an asset purchase agreement in respect of the acquisition of a portfolio with original pharmaceuticals
Reading Time: 3 minutes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES TO DISTRIBUTE THIS ANNOUNCEMENT. EQL
Universal Sompo General Insurance Collaborates with CRY to Empower Education for Marginalized Communities in Andhra Pradesh
Reading Time: 3 minutes Universal Sompo announced its collaboration with Child Rights and You (CRY) to foster educational opportunities for children in marginalized communities in Andhra Pradesh. The partnership comes on the eve of inauguration of Universal Sompo’s new corporate office in Mumbai. The initiative aims to address barriers
Aptahem’s Scientific Manuscript now Published in the British Journal of Pharmacology
Reading Time: 2 minutes Aptahem announced on 10 September 2024 that their scientific manuscript had been accepted for publication in the British Journal of Pharmacology (BJP). On the 9th December 2024, the article has been published. Read the article, titled “Antithrombotic but not anticoagulant activity
Theater Mogul’s “Defending the Caveman” Brings its Hilarious, Timeless Comedy to Mumbai
Reading Time: 3 minutes Mumbai has experienced and is applauding the laugh-out-loud humour of “Defending the Caveman,” the longest-running solo play in Broadway history, as it arrived in India for the first time! A comedic exploration of relationships, differences between men and women, and modern-day misunderstandings, this international sensation
Revised 2024 financial expectations and Accelerate25XL strategy update
Reading Time: 2 minutes Company Announcement no. 17/202410 December 2024 This announcement contains inside information concerning 2024 expectations and the Accelerate25XL strategy The Board of Directors for Wirtek A/S has today reviewed an updated financial prognosis for fiscal year 2024. Based on this review, the
JM acquiring building rights for residential development in Vaxholm
Reading Time: < 1 minute JM has signed an agreement with Brabo Stockholm AB for the acquisition of building rights for the development of approximately 60 residential units in Rindö Hamn, Vaxholm municipality. The transaction amounts to SEK 40m. The property being acquired is Rindö
Minesto completes Hestfjord Dragon Farm specification based on Dragon 12 achievements
Reading Time: 4 minutes After successful commissioning and four months of grid connected operation with Dragon 12, this autumn Minesto has focused on evaluation of powerplant performance, analysis of critical technical systems and operating procedures, as well as identification of selective upgrades of the megawatt-scale
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise Including BRUKINSA® and Novel Pipeline Assets
Reading Time: 12 minutes San Mateo, Calif., United States: 5-year follow-up from SEQUOIA study demonstrated treatment with BRUKINSA reduced the risk of progression or death by 71% compared to bendamustine-rituximab in patients with treatment-naïve CLL, further solidifying its position as the leader in new